✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Gennex Laboratories Ltd.

GENNEX

Market Cap
₹314 Cr.
P/E
16.88

Gennex Laboratories Ltd.

  • Gennex Lab
  • Trident Lifeline
  • Ambalal Sarabhai Ent
FAQs on Gennex Laboratories Ltd. Shareprice

Gennex Lab has given better returns compared to its competitors.
Gennex Lab has grown at ~54.11% over the last 2yrs while peers have grown at a median rate of 34.04%

Gennex Lab is not expensive.
Latest PE of Gennex Lab is 16.94, while 3 year average PE is 30.72.
Also latest EV/EBITDA of Gennex Lab is 12.64 while 3yr average is 18.23.

View FAQ's On Business
Growth Table
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Balance Sheet
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Cash Flow
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Quarterly Results
  • Gennex Laboratories Ltd.
  • Trident Lifeline
  • Ambalal Sarabhai Ent
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Gennex Laboratories Ltd. Financials

Balance sheet of Gennex Lab is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Gennex Lab is increasing.
Latest debt of Gennex Lab is -₹23.21 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹94.99 Crs.

Yes, profit is increasing.
The profit of Gennex Lab is ₹19.59 Crs for TTM, ₹11.37 Crs for Mar 2024 and ₹6.19 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Gennex Lab latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech